Symrise AG Unsponsored ADR (OTCMKTS:SYIEY - Get Free Report) saw a significant increase in short interest in October. As of October 15th, there was short interest totaling 14,944 shares, an increase of 139.8% from the September 30th total of 6,233 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 77,509 shares, the days-to-cover ratio is currently 0.2 days.
Analyst Upgrades and Downgrades
Several research analysts have commented on SYIEY shares. Jefferies Financial Group raised shares of Symrise from a "hold" rating to a "buy" rating in a research note on Tuesday, September 1st. Sanford C. Bernstein upgraded shares of Symrise to a "hold" rating in a research report on Wednesday, July 22nd. Morgan Stanley reissued an "overweight" rating on shares of Symrise in a research note on Thursday, August 27th. Finally, Citigroup restated a "buy" rating on shares of Symrise in a report on Friday, September 25th. Four investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Symrise presently has a consensus rating of "Moderate Buy".
Get Our Latest Stock Analysis on Symrise
Symrise Price Performance
OTCMKTS SYIEY opened at $25.60 on Friday. Symrise has a one year low of $19.31 and a one year high of $28.77. The business has a fifty day moving average price of $26.47 and a 200 day moving average price of $23.73.
About Symrise
(
Get Free Report)
Symrise AG is a global chemicals and ingredients company headquartered in Holzminden, Germany. It develops, manufactures and markets flavorings, fragrances, cosmetic ingredients, food ingredients and nutritional solutions for customers in the food and beverage, consumer goods, cosmetics, personal care and pet food industries.
The company's products include flavor compounds for food and beverages, fragrance ingredients and finished fragrances for perfumes and household products, as well as active and functional ingredients used in skin care, hair care and other personal care applications.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Symrise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Symrise wasn't on the list.
While Symrise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.